Several works agree on TGF-β as a key molecule involved in Treg-driven NK cell inhibition because of its ability to suppress NK-cell-mediated tumor killing and to reduce NKG2D and IFN-γ expression [95,98,99,100,101,102]. This evidence concerns the gene KLRK1 and neoplasm.